SUN PHARMA ADVANCED RESEARCH COMPANY
Back to Balance Sheet
|
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Net Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹1,108 Cr | ₹-348 Cr | ₹4.33 Cr | ₹276 Cr |
What is the latest Net Current Assets ratio of SUN PHARMA ADVANCED RESEARCH COMPANY ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹1,108 Cr |
| Mar2025 | ₹-348 Cr |
| Mar2024 | ₹4.33 Cr |
| Mar2023 | ₹276 Cr |
How is Net Current Assets of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,108 Cr | Positive | |
| Mar2025 | ₹-348 Cr | Negative | |
| Mar2024 | ₹4.33 Cr | -98.43 | |
| Mar2023 | ₹276 Cr | - | |
Compare Net Current Assets of peers of SUN PHARMA ADVANCED RESEARCH COMPANY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMA ADVANCED RESEARCH COMPANY | ₹7,022.2 Cr | -4.9% | -4.7% | 33% | Stock Analytics | |
| PRIME FOCUS | ₹22,448.3 Cr | 1.7% | 35% | 67% | Stock Analytics | |
| SAGILITY | ₹18,940.7 Cr | -2.1% | 1% | -8.1% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹16,413.2 Cr | -2.6% | -8.2% | -39.8% | Stock Analytics | |
| INTERNATIONAL GEMOLOGICAL INSTITUTE | ₹14,639.4 Cr | -0.9% | -3.8% | -11.6% | Stock Analytics | |
| INDEGENE | ₹11,870.4 Cr | -3.2% | -6.5% | -15.5% | Stock Analytics | |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMA ADVANCED RESEARCH COMPANY | -4.9% |
-4.7% |
33% |
| SENSEX | -2.7% |
-0.2% |
-8% |
You may also like the below Video Courses